GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » JMI Syringes & Medical Devices Ltd (DHA:JMISMDL) » Definitions » Capex-to-Revenue

JMI Syringes & Medical Devices (DHA:JMISMDL) Capex-to-Revenue : 0.00 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is JMI Syringes & Medical Devices Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

JMI Syringes & Medical Devices's Capital Expenditure for the three months ended in Dec. 2023 was BDT0.00 Mil. Its Revenue for the three months ended in Dec. 2023 was BDT452.98 Mil.

Hence, JMI Syringes & Medical Devices's Capex-to-Revenue for the three months ended in Dec. 2023 was 0.00.


JMI Syringes & Medical Devices Capex-to-Revenue Historical Data

The historical data trend for JMI Syringes & Medical Devices's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JMI Syringes & Medical Devices Capex-to-Revenue Chart

JMI Syringes & Medical Devices Annual Data
Trend Dec14 Dec15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

JMI Syringes & Medical Devices Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of JMI Syringes & Medical Devices's Capex-to-Revenue

For the Medical Instruments & Supplies subindustry, JMI Syringes & Medical Devices's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JMI Syringes & Medical Devices's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, JMI Syringes & Medical Devices's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where JMI Syringes & Medical Devices's Capex-to-Revenue falls into.



JMI Syringes & Medical Devices Capex-to-Revenue Calculation

JMI Syringes & Medical Devices's Capex-to-Revenue for the fiscal year that ended in Jun. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 1755.167
=0.00

JMI Syringes & Medical Devices's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 452.983
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


JMI Syringes & Medical Devices  (DHA:JMISMDL) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


JMI Syringes & Medical Devices Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of JMI Syringes & Medical Devices's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


JMI Syringes & Medical Devices (DHA:JMISMDL) Business Description

Traded in Other Exchanges
N/A
Address
117, Kazi Nazrul Islam Avenue, Unique Heights, Level-11, Ramna, Dhaka, BGD, 1217
JMI Syringes & Medical Devices Ltd is a Bangladesh-based syringe and medical device manufacturing company. It manufactures and markets disposable syringe, auto-disable syringe, needle, infusion set, scalp vein set, urine drainage bag, insulin syringe, First AID bandage, riles tube, IV Cannula, feeding tube, and Blood Lancets, and other products.

JMI Syringes & Medical Devices (DHA:JMISMDL) Headlines

No Headlines